Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1956 1
1959 1
1977 1
1984 1
1989 2
1990 1
1993 1
1995 1
1998 1
1999 2
2001 1
2002 2
2003 1
2008 2
2009 2
2010 3
2011 1
2013 4
2014 4
2015 3
2016 2
2017 2
2018 5
2019 4
2020 6
2021 6
2022 10
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Current management of giant-cell tumor of bone in the denosumab era.
Nagano A, Urakawa H, Tanaka K, Ozaki T. Nagano A, et al. Jpn J Clin Oncol. 2022 May 5;52(5):411-416. doi: 10.1093/jjco/hyac018. Jpn J Clin Oncol. 2022. PMID: 35199172 Review.
Giant-cell tumor of bone is a rare, locally aggressive and rarely metastasizing primary bone tumor. ...In systematic reviews of the local recurrence rate after preoperative use of denosumab, conclusions vary due to the small sample sizes …
Giant-cell tumor of bone is a rare, locally aggressive and rarely metastasizing primary bone tumor …
Giant cell tumor of bone: current treatment options.
Skubitz KM. Skubitz KM. Curr Treat Options Oncol. 2014 Sep;15(3):507-18. doi: 10.1007/s11864-014-0289-1. Curr Treat Options Oncol. 2014. PMID: 24788576 Review.
Giant cell tumor of bone (GCTB) comprises up to 20 % of benign bone tumors in the US. ...When the morbidity of surgery would be excessive, radiation therapy may achieve local control. In most cases the primary driver of the malignant c …
Giant cell tumor of bone (GCTB) comprises up to 20 % of benign bone tumors in the US. ...When the morbidi …
Updated concepts in treatment of giant cell tumor of bone.
van der Heijden L, Lipplaa A, van Langevelde K, Bovée JVMG, van de Sande MAJ, Gelderblom H. van der Heijden L, et al. Curr Opin Oncol. 2022 Jul 1;34(4):371-378. doi: 10.1097/CCO.0000000000000852. Curr Opin Oncol. 2022. PMID: 35837707 Review.
PURPOSE OF REVIEW: Giant cell tumors of bone (GCTB) are intermediate, locally aggressive primary bone tumors. ...The most frequent mutation (G34W) can be detected using immunohistochemistry and is highly specific in differentiating GCTB from other g …
PURPOSE OF REVIEW: Giant cell tumors of bone (GCTB) are intermediate, locally aggressive primary bone tumors. .. …
The multidisciplinary management of giant cell tumor of bone.
Ng VY, Davidson DJ, Kim EY, Pollack SM, Conrad Iii EU, Jones RL. Ng VY, et al. Expert Rev Anticancer Ther. 2014 Jul;14(7):783-90. doi: 10.1586/14737140.2014.901891. Epub 2014 Mar 26. Expert Rev Anticancer Ther. 2014. PMID: 24666240 Review.
Giant cell tumor of bone is a locally aggressive lesion with a predilection for local recurrence, and in a small proportion of patients, metastatic disease can develop. ...There are limited data regarding other treatment modalities such as radiation …
Giant cell tumor of bone is a locally aggressive lesion with a predilection for local recurrence, and in a small …
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas.
Albarrán V, Villamayor ML, Chamorro J, Rosero DI, Pozas J, San Román M, Calvo JC, Pérez de Aguado P, Moreno J, Guerrero P, González C, García de Quevedo C, Álvarez-Ballesteros P, Vaz MÁ. Albarrán V, et al. Int J Mol Sci. 2022 Nov 9;23(22):13784. doi: 10.3390/ijms232213784. Int J Mol Sci. 2022. PMID: 36430263 Free PMC article. Review.
Although the development of TKIs for other primary bone tumors is less advanced, preclinical data and early trials have begun to show their potential benefit in advanced Ewing sarcoma (ES) and rarer bone tumors (chondrosarcoma, chordoma, giant cell …
Although the development of TKIs for other primary bone tumors is less advanced, preclinical data and early trials have begun to show …
Updates in the treatment of bone cancer.
Biermann JS. Biermann JS. J Natl Compr Canc Netw. 2013 May;11(5 Suppl):681-3. doi: 10.6004/jnccn.2013.0200. J Natl Compr Canc Netw. 2013. PMID: 23704242 Review.
Although extremely rare, primary bone cancers are often curable with proper treatment. Effective management of primary bone tumors hinges on the involvement of a multidisciplinary team of physicians with expertise in this area, both in the realms of diagnosis and tr …
Although extremely rare, primary bone cancers are often curable with proper treatment. Effective management of primary bone tu …
Giant cell tumor of bone: review, mimics, and new developments in treatment.
Chakarun CJ, Forrester DM, Gottsegen CJ, Patel DB, White EA, Matcuk GR Jr. Chakarun CJ, et al. Radiographics. 2013 Jan-Feb;33(1):197-211. doi: 10.1148/rg.331125089. Radiographics. 2013. PMID: 23322837 Review.
Giant cell tumor (GCT) of bone is generally a benign tumor composed of mononuclear stromal cells and characteristic multinucleated giant cells that exhibit osteoclastic activity. ...Denosumab, a monoclonal antibody that targets the osteoc …
Giant cell tumor (GCT) of bone is generally a benign tumor composed of mononuclear stromal cells and char …
Giant Cell Tumor of Bone: Review of Current Literature, Evaluation, and Treatment Options.
Montgomery C, Couch C, Emory CL, Nicholas R. Montgomery C, et al. J Knee Surg. 2019 Apr;32(4):331-336. doi: 10.1055/s-0038-1675815. Epub 2018 Nov 16. J Knee Surg. 2019. PMID: 30449024 Review.
Giant cell tumor of bone is a benign albeit aggressive tumor commonly affecting the bones of the knee. ...For decades, surgical management has been the primary treatment for giant cell tumor of the bone. Some tumors c …
Giant cell tumor of bone is a benign albeit aggressive tumor commonly affecting the bones of the knee. .. …
Giant Cell Tumor (tumor gigantocellularis, osteoclastoma) - epidemiology, diagnosis, treatment.
Karpik M. Karpik M. Ortop Traumatol Rehabil. 2010 May-Jun;12(3):207-15. Ortop Traumatol Rehabil. 2010. PMID: 20675862 Review. English, Polish.
The author presents the epidemiology, classification, clinical features and strategies of treatment of Giant Cell Tumor. Giant Cell Tumor of Bone accounts for 4-8% of primary bone tumors. ...The recurrence rate is high (12-5 …
The author presents the epidemiology, classification, clinical features and strategies of treatment of Giant Cell Tumor …
Denosumab: a new treatment option for giant cell tumor of bone.
Lewin J, Thomas D. Lewin J, et al. Drugs Today (Barc). 2013 Nov;49(11):693-700. doi: 10.1358/dot.2013.49.11.2064725. Drugs Today (Barc). 2013. PMID: 24308016 Review.
Giant cell tumor of bone (GCTB) is an osteolytic, usually benign neoplasm characterized by infiltration with osteoclast-like giant cells, and the osteoclast differentiation factor receptor activator of nuclear factor kappa-B ligand (RANKL) is he …
Giant cell tumor of bone (GCTB) is an osteolytic, usually benign neoplasm characterized by infiltration with ost …
70 results